The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 05, 2000

Filed:

Feb. 18, 1999
Applicant:
Inventors:

Masafumi Arita, Chikujo-gun, JP;

Tadamasa Saitoh, Iruma, JP;

Masanori Minoguchi, Iruma, JP;

Keiji Yamagami, Iruma, JP;

Hiroyuki Satoh, Chikujo-gun, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K / ; A61K / ; C07D / ; C07D / ; A61P / ;
U.S. Cl.
CPC ...
514300 ; 514241 ; 514247 ; 514246 ; 514249 ; 514258 ; 514261 ; 514301 ; 514303 ; 514311 ; 514313 ; 514352 ; 514384 ; 540180 ; 540184 ; 544182 ; 544194 ; 544224 ; 544254 ; 544277 ; 544280 ; 544258 ; 544298 ; 544322 ; 544336 ; 544331 ; 544362 ; 546113 ; 546117 ; 546118 ; 546119 ; 546122 ; 546164 ; 546174 ;
Abstract

Benzamide compounds of the formula ##STR1## wherein each symbol is defined in the specification, isomers thereof and pharmaceutically acceptable acid addition salts thereof. Pharmaceutical compositions comprising a therapeutically effective amount of this compound and a pharamaceutically acceptable additive, and therapeutic agents for hypertension, therapeutic agents for angina pectoris, therapeutic agent for asthma, therapeutic agents for renal and peripheral circulatory disturbances and inhibitor of cerebral vasospasm, which comprise this compound. The compound of the present invention has strong smooth muscle relaxing action, and shows hypertensive action and cerebral.cndot.coronary vasodilating action like conventional calcium antagonists, as well as long-lasting renal and peripheral circulation improving action. Unlike calcium antagonists, it permits oral administration to suppress vascular contraction caused by various agonists, and is useful as a strong and long-acting agent for prophylaxis and treatment of circulatory diseases in coronary, cerebral, renal and peripheral arteries, as a therapeutic agent for hypertension, angina pectoris, and renal and peripheral circulation disorder, an inhibitor of cerebral vasospasm and the like. Moreover, the compound of the present invention is useful as a therapeutic agent for asthma.


Find Patent Forward Citations

Loading…